Top

Breast Cancer

Published in:

01-08-2000 | Original Article

Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report

Authors: Takao Yokoe, Yuichi lino, Yasuo Morishita

Published in: Breast Cancer | Issue 3/2000

Title: Trends of IL-6 and IL-8 levels in patients with recurrent breast cancer: preliminary report
Authors: Takao Yokoe
Yuichi lino
Yasuo Morishita
Publication date: 01-08-2000
Publisher: Springer-Verlag
Published in: Breast Cancer / Issue 3/2000
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI: https://doi.org/10.1007/BF02967458

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2000

Cytokines facilitate chemotactic motility of breast carcinoma cells

A case report of advanced male breast cancer with an objective response to tamoxifen treatment

Interstitial brachytherapy for recurrent breast cancer using a high dose rate lr-192 remote afterloading system: a report of two cases

Significance of the parathyroid hormone-related protein expression in breast carcinoma

Audit of a one-stop breast clinic-revisited

Determination of optimal radiation energy for different breast sizes using ct-simulatior in tangential breast irradiation

Keynote webinar | Spotlight on antibody–drug conjugates in cancer